Clin Cancer Res 2009, 15:6018–6027.PubMedCentralPubMedCrossRef 45. Segawa E, Kishimoto H, Takaoka K,

Noguchi K, Hashitani S, Sakurai K, Urade M: Promotion of hematogenous metastatic potentials in human KB carcinoma cells with overexpression of cyclooxygenase-2. Oncol Rep 2010, 24:733–739.PubMed Fulvestrant in vivo 46. Nakayama S, Sasaki A, Mese H, Alcalde RE, Tsuji T, Matsumura T: The E-cadherin gene is silenced by CpG methylation in human oral squamous cell carcinomas. Int J Cancer 2001, 9:667–673.CrossRef 47. Maeda G, Chiba T, Okazaki M, Satoh T, Taya Y, Aoba T, Kato K, Kawashiri S, Imai K: Expression of SIP1 in oral squamous cell carcinomas: implications for E-cadherin expression and tumor progression. Int J Oncol 2005, 27:1535–1541.PubMed 48. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D, van Roy F: The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 2001, 7:1267–1278.PubMedCrossRef 49. Miyoshi A, Kitajima Y, Sumi K, Sato K, Hagiwara A, Koga Y, Miyazaki K: Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells. Br J Cancer 2004, 90:1265–1273.PubMedCentralPubMedCrossRef 50. Tsubaki M, Komai M, Fujimoto S, Itoh T, Imano M, Sakamoto K, Shimaoka

H, Takeda T, Ogawa N, Mashimo K, Fujiwara D, Mukai J, AZD5363 Sakaguchi K, Satou T, Nishida S: Activation of NF-kappaB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines. J Exp Clin Cancer Res 2013, 32:62.PubMedCentralPubMedCrossRef 51. Hong KO, Kim JH, Hong JS, Yoon HJ, Lee JI, Hong SP, Hong SD: Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB

and KOSCC-25B oral squamous cell carcinoma cells. J Exp Clin Cancer Res 2009, 28:28.PubMedCentralPubMedCrossRef 52. Kinugasa Y, Hatori M, Ito H, Kurihara Y, Ito D, Nagumo M: Inhibition of cyclooxygenase-2 suppresses invasiveness of oral squamous cell carcinoma cell lines via down-regulation of matrix metalloproteinase-2 and CD44. Clin Exp Metastasis 2005, 21:737–745.CrossRef Ponatinib 53. Kurihara Y, Hatori M, Ando Y, Ito D, Toyoshima T, Tanaka M, Shintani S: Inhibition of cyclooxygenase-2 suppresses the invasiveness of oral squamous cell carcinoma cell lines via down-regulation of matrix metalloproteinase-2 production and activation. Clin Exp Metastasis 2009, 26:425–432.PubMedCrossRef 54. Kim YY, Lee EJ, Kim YK, Kim SM, Park JY, Myoung H, Kim MJ: Anti-cancer effects of celecoxib in head and neck carcinoma. Mol Cells 2010, 29:185–194.PubMedCrossRef 55. Ko SH, Choi GJ, Lee JH, Han YA, Lim SJ, Kim SH: Differential effects of selective cyclooxygenase-2 inhibitors in inhibiting proliferation and induction of apoptosis in oral squamous cell carcinoma. Oncol Rep 2008, 19:425–433.PubMed 56.